- Hem
- Om universitetet
- Hitta person
- Markus Axelsson
Markus Axelsson
Docent
Sektionen för klinisk neurovetenskap-
Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple
Sclerosis
Sofia Sandgren, Lenka Nováková Nyrén, Markus Axelsson, Igal Rosenstein, Jan Lycke, Clas Malmeström
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION - 2025 -
Association between pro-inflammatory proteins and neurofilament in plasma from persons with
epilepsy
Mayuresh Sarangdhar, Sarah Akel, Saman Hosseini Ashtiani, Markus Axelsson, Johan Zelano
BMC MEDICINE - 2025 -
The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life
use.
Magnus Johnsson, Kajsa Eriksson, Igal Rosenstein, Lenka Nováková Nyrén, Clas Malmeström, Jan Lycke, Sofia Sandgren, Henrik Zetterberg, Kaj Blennow, Kalle Johansson, Markus Axelsson
Multiple Sclerosis and Related Disorders - 2025 -
Cerebrospinal fluid alpha-internexin is increased in patients with multiple sclerosis and correlates strongly with neurofilament light
protein.
Magnus Johnsson, Meda Fj, Jan Lycke, Lenka Nováková Nyrén, Igal Rosenstein, Johansson K, Clas Malmeström, Henrik Zetterberg, Hlin Kvartsberg, Markus Axelsson
Multiple Sclerosis and Related Disorders - 2025 -
Validation of a plasma GFAP immunoassay and establishment of age-related reference values: bridging analytical performance and routine
implementation
Burak Arslan, Ulf Andreasson, Elzbieta Rembeza, Markus Axelsson, Lenka Nováková Nyrén, Bjorn-Eivind Kirsebom, Tormod Fladby, Anna Dittrich, Silke Kern, Ingmar Skoog, Kaj Blennow, Henrik Zetterberg, Hlin Kvartsberg
CLINICAL CHEMISTRY AND LABORATORY MEDICINE - 2025 -
Plasma concentrations of neurofilament light, p-Tau231 and glial fibrillary acidic protein are elevated in patients with chronic kidney disease and correlate with measured glomerular filtration
rate
Torunn Høie Axelsson, Henrik Zetterberg, Kaj Blennow, Burak Arslan, Nicholas J. Ashton, Markus Axelsson, Maria K. Svensson, Aso Saeed, Gregor Guron
BMC Nephrology - 2025 -
Plateau of practice effects and noise with repeat SDMT testing and in multiple
sclerosis
Lenka Novakova, Igal Rosenstein, Markus Axelsson, Menno M. Schoonheim, Ralph H. B. Benedict, Tom A. Fuchs
MULTIPLE SCLEROSIS JOURNAL - 2025 -
Ion concentrations in CSF and serum are differentially and precisely
regulated
Tim Lyckenvik, My Forsberg, Kalle Johansson, Markus Axelsson, Henrik Zetterberg, Kaj Blennow, Sebastian Illes, Pontus Wasling, Eric Hanse
BRAIN COMMUNICATIONS - 2025 -
Cerebrospinal Fluid Biomarkers in Opioid Dependence: Evidence of Neuroimmune Activation and Ion Composition Changes, Without Alteration in
Orexin-A
Tim Lyckenvik, Malin Woock, Kalle Johansson, Markus Axelsson, Henrik Zetterberg, Kaj Blennow, Eric Hanse, Pontus Wasling
ADDICTION BIOLOGY - 2025 -
Brain-Derived Tau as an Outcome Marker in Guillain-Barré Syndrome: A Retrospective Cohort
Study
Brynhildur Hafsteinsdottir, Fernando Gonzalez-Ortiz, Nina Gleisner, Ellen Alpsten, Jan Lycke, Igal Rosenstein, Lenka Novakova, Kaj Blennow, Tomas Bergström, Henrik Zetterberg, Markus Axelsson
EUROPEAN JOURNAL OF NEUROLOGY - 2025 -
Higher plasma neurofilament-light chain concentration in drug-resistant
epilepsy
Sarah Akel, Markus Axelsson, Fredrik Asztely, Henrik Zetterberg, Johan Zelano
BRAIN COMMUNICATIONS - 2025 -
Quality of life is decreased in persons with relapsing-remitting multiple sclerosis experiencing progression independent of relapse
activity
Sarah Lindberg, Sofia Sandgren, Markus Axelsson, Igal Rosenstein, Jan Lycke, Lenka Novakova
MULTIPLE SCLEROSIS JOURNAL - 2025 -
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple
sclerosis.
Igal Rosenstein, Anna Nordin, Hemin Sabir, Clas Malmeström, Kaj Blennow, Markus Axelsson, Lenka Novakova
Journal of neurology - 2024 -
Tyro3 and Gas6 are associated with white matter and myelin integrity in multiple
sclerosis.
Igal Rosenstein, Lenka Nováková Nyrén, Hlin Kvartsberg, Anna Nordin, Sofia Rasch, Elzbieta Rembeza, Sofia Sandgren, Clas Malmeström, Stefanie Fruhwürth, Markus Axelsson, Kaj Blennow, Henrik Zetterberg, Jan Lycke
Journal of Neuroinflammation - 2024 -
CSF biomarkers of neurotoxicity in childhood cancer survivors after cranial radiotherapy or
surgery.
Erik Fernström, Marianne Jarfelt, Malin Blomstrand, Birgitta Lannering, Markus Axelsson, Pontus Wasling, Thomas Björk-Eriksson, Henrik Zetterberg, Marie Kalm
Annals of clinical and translational neurology - 2024 -
The effect of alemtuzumab on neurodegeneration in relapsing-remitting multiple sclerosis: A five-year prospective mono-center
study
Sofia Sandgren, Lenka Novakova, Anna Nordin, Hemin Sabir, Markus Axelsson, Clas Malmeström, Henrik Zetterberg, Jan Lycke
MULTIPLE SCLEROSIS AND RELATED DISORDERS - 2024 -
Neurofilament light chain as a diagnostic and prognostic biomarker in Guillain-Barré
syndrome
Brynhildur Hafsteinsdottir, Helen H. Farman, Nina Lagerstrom, Henrik Zetterberg, Oluf Andersen, Lenka Novakova, Bengt Nellgård, Hans Rosén, Clas Malmeström, Igal Rosenstein, Jan Lycke, Markus Axelsson
JOURNAL OF NEUROLOGY - 2024 -
A prospective feasibility trial exploring novel biomarkers for neurotoxicity after isolated limb
perfusion
Anna Corderfeldt, Markus Axelsson, G. Bragadottir, Kaj Blennow, Henrik Zetterberg, Roger Olofsson Bagge
Perfusion - 2024 -
High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in
ALS
Christoffer Rosén, Bernardo Mitre, Bengt Nellgård, Markus Axelsson, Radu Constantinescu, Peter Munch Andersen, Keti Dalla, Kaj Blennow, Gustav Nilsson, Henrik Zetterberg, Hans Rosén
JOURNAL OF THE NEUROLOGICAL SCIENCES - 2024 -
Standard versus High Cardiopulmonary Bypass Flow Rate: A Randomized Controlled Subtrial Comparing Brain Injury Biomarker
Release
Anna Corderfeldt Keiller, Markus Axelsson, Gudrun Bragadottir, Lukas Lannemyr, Johanna Wijk, Kaj Blennow, Henrik Zetterberg, Roger Olofsson Bagge
Journal of Cardiothoracic and Vascular Anesthesia - 2024 -
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center
study
Magnus Johnsson, Y. T. Stenberg, H. H. Farman, Kaj Blennow, Henrik Zetterberg, Clas Malmeström, Sofia Sandgren, Igal Rosenstein, Jan Lycke, Markus Axelsson, Lenka Novakova
MULTIPLE SCLEROSIS JOURNAL - 2024 -
Medically unexplained symptoms are common in women in tertiary neurological healthcare center: A survey cohort study of persons investigated for suspected multiple
sclerosis
Lenka Novakova, Anna Karin Hedstrom, Markus Axelsson, Anne Brandt, Lars Alfredsson, Tomas Olsson, Jan Lycke
BRAIN AND BEHAVIOR - 2024 -
High temperature requirement A1 and macrophage migration inhibitory factor in the cerebrospinal fluid; a potential marker of conversion from relapsing-remitting to secondary progressive multiple
sclerosis
Simone Hjæresen, Eirikur Benedikz, Tobias Sejbaek, Markus Axelsson, Lenka Novakova, Mengliang Zhang, Jan Lycke, Zsolt Illes, Åsa Fex-Svenningsen
Journal of the Neurological Sciences - 2024 -
Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to
seizures
Sarah Akel, Fredrik Asztely, Rakesh Kumar Banote, Markus Axelsson, Henrik Zetterberg, Johan Zelano
Epilepsia - 2023 -
Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing-remitting multiple
sclerosis
Igal Rosenstein, Markus Axelsson, Lenka Novakova, Clas Malmeström, Kaj Blennow, Henrik Zetterberg, Jan Lycke
Journal of Neurology - 2023 -
A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple
sclerosis.
Sofia Sandgren, Lenka Nováková Nyrén, Anna Nordin, Markus Axelsson, Clas Malmeström, Henrik Zetterberg, Jan Lycke
Frontiers in neurology - 2023 -
The impact of hybrid immunity on immune responses after SARS-CoV-2 vaccination in persons with multiple sclerosis treated with disease-modifying
therapies
M. Rabenstein, O. G. Thomas, G. Carlin, M. Khademi, K. A. Högelin, Clas Malmeström, Markus Axelsson, Anne Brandt, G. Gafvelin, H. Grönlund, I. Kockum, F. Piehl, Jan Lycke, T. Olsson, T. Hessa
European Journal of Neurology - 2023 -
Presence of neural surface and onconeural autoantibodies in cerebrospinal fluid and serum in neurological diseases presents a potential risk for
misdiagnosis
Oskar Stevens-Jones, Clas Malmeström, Clara Constantinescu, Keti Dalla, Bengt Nellgård, Johan Zelano, Radu Constantinescu, Markus Axelsson
European Journal of Neurology - 2023 -
CYBA allelic variants are associated with severity and recovery in Guillain-Barré
syndrome
Andreas Törnell, Nina Lagerström, Natalia Mossberg, Roberta Kiffin, Helen H. Farman, Jan Lycke, Oluf Andersen, Markus Axelsson, Kristoffer Hellstrand, Anna Martner
Journal of the peripheral nervous system - 2023 -
Cerebrospinal fluid sulfatide isoforms lack diagnostic utility in separating progressive from relapsing-remitting multiple
sclerosis.
Lenka Novakova, Marcus Henricsson, Elias Björnson, Markus Axelsson, Jan Borén, Igal Rosenstein, Jan Lycke, Susanna Cardell, Maria K. Blomqvist
Multiple sclerosis and related disorders - 2023 -
Paraneoplastic or not? Sirtuin 2 in anti-N-methyl-D-aspartate receptor
encephalitis
Oskar Stevens-Jones, H. Mojzisova, M. Elisak, Radu Constantinescu, J. Hanzalova, Markus Axelsson, David Krysl
European Journal of Neurology - 2023 -
The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective
survey
Sofia Sandgren, Lenka Novakova, Markus Axelsson, Firoozeh Amirbeagi, I. Kockum, T. Olsson, Clas Malmeström, Jan Lycke
Frontiers in Neurology - 2023 -
High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple
sclerosis
Igal Rosenstein, Markus Axelsson, Lenka Novakova, S. Rasch, Kaj Blennow, Henrik Zetterberg, Jan Lycke
FRONTIERS IN IMMUNOLOGY - 2023 -
Decreased incidence of Guillain-Barre syndrome during the COVID-19 pandemic: a retrospective population-based
study
Brynhildur Hafsteinsdottir, Ellen Dalemo, O. Eliasdottir, E. Olafsson, Markus Axelsson
Neuroepidemiology - 2023 -
MIF in the cerebrospinal fluid is decreased during relapsing-remitting while increased in secondary progressive multiple
sclerosis
S. Hjaeresen, T. Sejbaek, Markus Axelsson, S. K. Mortensen, H. Vinslov-Jensen, G. Pihl-Jensen, Lenka Novakova, C. B. Pedersen, B. Halle, F. R. Poulsen, M. L. Zhang, E. Benedikz, J. L. Frederiksen, Jan Lycke, Z. Illes, A. Fex-Svenningsen
Journal of the Neurological Sciences - 2022 -
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled
trial
A. Svenningsson, T. Frisell, J. Burman, J. Salzer, K. Fink, S. Hallberg, J. Hambraeus, Markus Axelsson, F. Al Nimer, P. Sundstrom, M. Gunnarsson, R. Johansson, J. Mellergard, Igal Rosenstein, A. Ayad, I. Sjoblom, A. Risedal, P. de Flon, Eric Gilland, J. Lindeberg, F. Shawket, F. Piehl, Jan Lycke
Lancet Neurology - 2022 -
Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple
sclerosis
Igal Rosenstein, S. Rasch, Markus Axelsson, Lenka Novakova, Kaj Blennow, Henrik Zetterberg, Jan Lycke
Frontiers in Immunology - 2022 -
No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of
natalizumab
Magnus Johnsson, Helen H. Farman, Kaj Blennow, Henrik Zetterberg, Clas Malmeström, Markus Axelsson, Jan Lycke
Multiple Sclerosis Journal - 2022 -
Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot
study
Kalle Johansson, Pontus Wasling, Lenka Novakova, S. Sjodin, Ann Brinkmalm, Gunnar Brinkmalm, Kaj Blennow, Henrik Zetterberg, Markus Axelsson
Multiple Sclerosis and Related Disorders - 2022 -
SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated
disorder
Magnus Johnsson, Fredrik Asztely, S. Hejnebo, Markus Axelsson, Clas Malmeström, T. Olausson, Jan Lycke
Annals of Clinical and Translational Neurology - 2022 -
Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based
study
Igal Rosenstein, Markus Axelsson, Lenka Novakova, Kaj Blennow, Henrik Zetterberg, Jan Lycke
Multiple Sclerosis Journal - 2022 -
Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus
narcolepsy
Kalle Johansson, Pontus Wasling, Markus Axelsson
Acta Neurologica Scandinavica - 2021 -
Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple
sclerosis
Daniel Jons, Linn Persson Berg, P. Sundstrom, Sara Haghighi, Markus Axelsson, M. Thulin, Tomas Bergström, Oluf Andersen
Multiple Sclerosis and Related Disorders - 2021 -
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world
investigation
Igal Rosenstein, S. Rasch, Markus Axelsson, Lenka Novakova, Kaj Blennow, Henrik Zetterberg, Jan Lycke
Journal of Neurochemistry - 2021 -
A multicentre validation study of the diagnostic value of plasma neurofilament
light.
Nicholas J. Ashton, Shorena Janelidze, Ahmad Al Khleifat, Antoine Leuzy, Emma L van der Ende, Thomas Karikari, Andrea L Benedet, Tharick A Pascoal, Alberto Lleó, Lucilla Parnetti, Daniela Galimberti, Laura Bonanni, Andrea Pilotto, Alessandro Padovani, Jan Lycke, Lenka Novakova, Markus Axelsson, Latha Velayudhan, Gil D Rabinovici, Bruce Miller, Carmine Pariante, Naghmeh Nikkheslat, Susan M Resnick, Madhav Thambisetty, Michael Schöll, Gorka Fernández-Eulate, Francisco J Gil-Bea, Adolfo López de Munain, Ammar Al-Chalabi, Pedro Rosa-Neto, Andre Strydom, Per Svenningsson, Erik Stomrud, Alexander Santillo, Dag Aarsland, John C van Swieten, Sebastian Palmqvist, Henrik Zetterberg, Kaj Blennow, Abdul Hye, Oskar Hansson
Nature communications - 2021 -
Persons with suspicious onset of multiple sclerosis but with undetermined diagnosis had persistent lower cognition and reduced quality of
life
Clara Constantinescu, Lenka Novakova, Clas Malmeström, Radu Constantinescu, Markus Axelsson, Jan Lycke
Multiple Sclerosis and Related Disorders - 2021 -
The levels of the serine protease HTRA1 in cerebrospinal fluid correlate with progression and disability in multiple
sclerosis
S. Hjaeresen, T. Sejbaek, Markus Axelsson, H. Vinslov-Jensen, S. K. Mortensen, G. Pihl-Jensen, Lenka Novakova, J. D. R. Christensen, C. B. Pedersen, B. Halle, F. R. Poulsen, J. L. Frederiksen, M. L. Zhang, E. Benedikz, Jan Lycke, Z. Illes, A. F. Svenningsen
Journal of Neurology - 2021 -
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: An observational
study
Christina Zhukovsky, Sofia Sandgren, Thomas Silfverberg, Sigrun Einarsdottir, Andreas Tolf, Anne Marie Landtblom, Lenka Novakova, Markus Axelsson, Clas Malmeström, Honar Cherif, Kristina Carlson, Jan Lycke, Joachim Burman
Journal of Neurology, Neurosurgery and Psychiatry - 2021 -
Inflammation-related plasma and CSF biomarkers for multiple
sclerosis
J. Huang, M. Khademi, L. Fugger, O. Lindhe, Lenka Novakova, Markus Axelsson, Clas Malmeström, Clara Constantinescu, Jan Lycke, F. Piehl, T. Olsson, I. Kockum
Proceedings of the National Academy of Sciences of the United States of America - 2020 -
Intrathecal immunoreactivity in people with or without previous infectious
mononucleosis.
Daniel Jons, Henrik Zetterberg, Clas Malmeström, Tomas Bergström, Markus Axelsson, Kaj Blennow, Måns Thulin, Peter Sundström, Oluf Andersen
Acta neurologica Scandinavica - 2020
Fler publikationer
Antalet publikationer som visas på denna sida är begränsat. Besök Göteborgs Universitets publikationsdatabas (GUP) för att söka efter fler publikationer.